Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes.
暂无分享,去创建一个
T. Gillis | J. Mysore | M. MacDonald | R. Cole | S. Finkbeiner | G. Ming | Hongjun Song | C. Ross | M. Vawter | Yiping Shen | J. Gusella | J. Thomson | R. Margolis | Junying Yu | C. Svendsen | L. Thompson | G. Batugedara | J. Kaye | M. Casale | V. Mattis | A. Ebert | I. Seong | V. Wheeler | P. Donovan | Woon Kim | N. Allen | S. Winokur | E. Cattaneo | T. Ratovitski | Punita Sharma | N. Arbez | Xiaoli Chen | Georgia Makri | A. Battersby | P. Kemp | M. Onorati | D. Rushton | S. Akimov | E. Watkin | Virginia B. Mattis | L. Lock | A. Mason | R. S. Atwal | E. Fossale | A. W. Harrison | Jian Li | J. Chiang | Valentina Castiglioni | Soshana P. Svendsen | A. Redfern | Alvin R. King | S. Brazier | T. Juopperi | J. Arjomand | Aaron Daub | E. Chighladze | C. Zhong | Yu Zhu | H. Tseng | G. Makri | Soshana Svendsen | V. Castiglioni | A. W. J. Harrison
[1] Austin G Smith,et al. The first reported generation of several induced pluripotent stem cell lines from homozygous and heterozygous Huntington's disease patients demonstrates mutation related enhanced lysosomal activity , 2012, Neurobiology of Disease.
[2] C. Ross,et al. Age, CAG repeat length, and clinical progression in Huntington's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[3] S. Cole,et al. Sequences Human Induced Pluripotent Stem Cells Free of Vector and Transgene , 2012 .
[4] J. Mertens,et al. Excitation-induced ataxin-3 aggregation in neurons from patients with Machado–Joseph disease , 2011, Nature.
[5] M. Hayden,et al. Cholesterol metabolism in Huntington disease , 2011, Nature Reviews Neurology.
[6] M. MacDonald,et al. HD CAG-correlated gene expression changes support a simple dominant gain of function. , 2011, Human molecular genetics.
[7] R. Fernández‐Bolaños,et al. Important role of oxidative stress biomarkers in Huntington's disease. , 2011, Journal of medicinal chemistry.
[8] D. Krainc,et al. Mitochondrial Parkin Recruitment Is Impaired in Neurons Derived from Mutant PINK1 Induced Pluripotent Stem Cells , 2011, The Journal of Neuroscience.
[9] C. Svendsen,et al. Induced pluripotent stem cells: a new revolution for clinical neurology? , 2011, The Lancet Neurology.
[10] S. Haggarty,et al. Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis. , 2011, Human molecular genetics.
[11] Blake Byers,et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. , 2011, Cell stem cell.
[12] T. Timmusk,et al. Identification of cis-Elements and Transcription Factors Regulating Neuronal Activity-Dependent Transcription of Human BDNF Gene , 2011, The Journal of Neuroscience.
[13] U. Schmidt,et al. Derivation of Huntington's disease-affected human embryonic stem cell lines. , 2011, Stem cells and development.
[14] C. Ross,et al. Huntington's disease: from molecular pathogenesis to clinical treatment , 2011, The Lancet Neurology.
[15] Daniel T. Montoro,et al. Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells , 2010, PLoS currents.
[16] Cameron Torcassi,et al. Matrix Metalloproteinases Are Modifiers of Huntingtin Proteolysis and Toxicity in Huntington's Disease , 2010, Neuron.
[17] Elena Cattaneo,et al. Molecular mechanisms and potential therapeutical targets in Huntington's disease. , 2010, Physiological reviews.
[18] M. Guillermier,et al. In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects , 2010, Human molecular genetics.
[19] J. Alberch,et al. Impaired TrkB-mediated ERK1/2 Activation in Huntington Disease Knock-in Striatal Cells Involves Reduced p52/p46 Shc Expression* , 2010, The Journal of Biological Chemistry.
[20] Jane S. Paulsen,et al. CAG‐repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[21] M. Mehler,et al. Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease , 2009, Proceedings of the National Academy of Sciences.
[22] J. Jia,et al. Polymorphism of HD and UCHL-1 genes in Huntington’s disease , 2009, Journal of Clinical Neuroscience.
[23] E. Cattaneo,et al. Brain-derived neurotrophic factor in neurodegenerative diseases , 2009, Nature Reviews Neurology.
[24] R. Stewart,et al. Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences , 2009, Science.
[25] James A. Thomson,et al. Induced pluripotent stem cells from a spinal muscular atrophy patient , 2009, Nature.
[26] M. Peschanski,et al. Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats , 2008, Proceedings of the National Academy of Sciences.
[27] George Q. Daley,et al. Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.
[28] J. Marsh,et al. CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores BDNF levels in R6/2 mice , 2008, Molecular and Cellular Neuroscience.
[29] B. Thiers. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2008 .
[30] Shulan Tian,et al. Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.
[31] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[32] R. Bontrop,et al. Molecular evolution of the human SRPX2 gene that causes brain disorders of the Rolandic and Sylvian speech areas , 2007, BMC Genetics.
[33] Wenya Linda Bi,et al. Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain. , 2007, Human molecular genetics.
[34] L. Raymond,et al. N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease , 2007, Progress in Neurobiology.
[35] C. Ross,et al. Transcription meets metabolism in neurodegeneration , 2006, Nature Medicine.
[36] J. Olson,et al. Regional and cellular gene expression changes in human Huntington's disease brain. , 2006, Human molecular genetics.
[37] M. MacDonald,et al. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. , 2005, Human molecular genetics.
[38] S. Snyder,et al. p53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease , 2005, Neuron.
[39] Steven Finkbeiner,et al. Automated microscope system for determining factors that predict neuronal fate. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[40] Hervé Chneiweiss,et al. Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila. , 2005, Human molecular genetics.
[41] K. Takata,et al. High mobility group box protein‐1 inhibits microglial Aβ clearance and enhances Aβ neurotoxicity , 2004 .
[42] Mark R. Segal,et al. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death , 2004, Nature.
[43] C. Ross,et al. Protein aggregation and neurodegenerative disease , 2004, Nature Medicine.
[44] J. Poirier,et al. A role for lipoprotein lipase during synaptic remodeling in the adult mouse brain , 2004, Neurobiology of Disease.
[45] K. Takata,et al. High mobility group box protein-1 inhibits microglial Abeta clearance and enhances Abeta neurotoxicity. , 2004, Journal of neuroscience research.
[46] K. Lindenberg,et al. Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. , 2002, Brain : a journal of neurology.
[47] C A Ross,et al. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. , 2000, Human molecular genetics.
[48] Clive N Svendsen,et al. A new method for the rapid and long term growth of human neural precursor cells , 1998, Journal of Neuroscience Methods.
[49] C A Ross,et al. Correlation between the onset age of Huntington's disease and length of the trinucleotide repeat in IT-15. , 1993, Human molecular genetics.
[50] Manish S. Shah,et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.
[51] Joseph B. Martin. Huntington's disease , 1984, Neurology.